Koers Pangaea Oncology, S.A. BME
Aandelen
ES0105221008
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 13,8 mln. 14,97 mln. | Omzet 2025 * | 14,8 mln. 16,05 mln. | Marktkapitalisatie | 54,26 mln. 58,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -1 mln. -1,08 mln. | Nettowinst (verlies) 2025 * | - 0 | EV/omzet 2024 * | 4,33 x |
Nettoschuld 2024 * | 5,5 mln. 5,97 mln. | Nettoschuld 2025 * | 6,8 mln. 7,38 mln. | EV/omzet 2025 * | 4,13 x |
K/w-verhouding 2024 * |
-36
x | K/w-verhouding 2025 * |
-90
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 21,08% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 | |
Founder | - | 01-01-07 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,05% | 63,85 mld. | |
-2,02% | 41,83 mld. | |
+40,01% | 40,47 mld. | |
-10,22% | 27,17 mld. | |
+13,42% | 26,52 mld. | |
-21,60% | 18,69 mld. | |
+2,89% | 12,73 mld. | |
+22,40% | 12,11 mld. | |
+27,49% | 12,07 mld. |